Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Shariat

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Urology|May 9, 2001
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancerJ L Gore, S F Shariat, B J Miles, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimensH Tokunaga, S F Shariat, A E Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomyS F Shariat, M Shalev, A Menesses-Diaz, et al.
Hellenic Journal of Nuclear Medicine|January 12, 2018
Hematopoiesis is prognostic for toxicity and survival of <sup>223</sup>Radium treatment in patients with metastatic castration-resistant prostate cancerA Leisser, M Nejabat, M Hartenbach, et al.
Urology|February 13, 2001
E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladderS F Shariat, S Pahlavan, A G Baseman, et al.
Cancer|December 18, 2001
Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladderJ H Kim, S F Shariat, I Y Kim, et al.
The Journal of Urology|May 9, 2001
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followupR R Byrne, S F Shariat, R Brown, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 14, 2010
Tissue-based molecular markers for bladder cancerC E Barbieri, Y Lotan, R K Lee, et al.
European Journal of Radiology|July 8, 2022
Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy populationN Pötsch, E Rainer, P Clauser, et al.
Cancer|December 26, 2001
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinomaS F Shariat, J H Kim, B Andrews, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Urology|May 9, 2001
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancerJ L Gore, S F Shariat, B J Miles, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimensH Tokunaga, S F Shariat, A E Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomyS F Shariat, M Shalev, A Menesses-Diaz, et al.
Hellenic Journal of Nuclear Medicine|January 12, 2018
Hematopoiesis is prognostic for toxicity and survival of <sup>223</sup>Radium treatment in patients with metastatic castration-resistant prostate cancerA Leisser, M Nejabat, M Hartenbach, et al.
Urology|February 13, 2001
E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladderS F Shariat, S Pahlavan, A G Baseman, et al.
Cancer|December 18, 2001
Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladderJ H Kim, S F Shariat, I Y Kim, et al.
The Journal of Urology|May 9, 2001
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followupR R Byrne, S F Shariat, R Brown, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 14, 2010
Tissue-based molecular markers for bladder cancerC E Barbieri, Y Lotan, R K Lee, et al.
European Journal of Radiology|July 8, 2022
Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy populationN Pötsch, E Rainer, P Clauser, et al.
Cancer|December 26, 2001
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinomaS F Shariat, J H Kim, B Andrews, et al.
Pageof 10